Ergoteles’s Cabot Corp CBT Stock Holding History

Ergoteles’s Portfolio CBT Stock Details CBT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-19,988	Closed	-$1.34M	–	1308
2022 Q4	$1.34M	Buy	+19,988	New	+$1.4M	0.05%	382
2022 Q3	–	Sell	-8,760	Closed	-$559K	–	1582
2022 Q2	$559K	Buy	+8,760	New	+$599K	0.02%	793
2022 Q1	–	Sell	-3,873	Closed	-$218K	–	1261
2021 Q4	$218K	Buy	+3,873	New	+$213K	0.01%	987

Other funds holding CBT

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

SCM

Snyder Capital Management San Francisco, California $5.16B AUM 26.72% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Ergoteles's CBT Position: Q1 2023 in Review

Ergoteles sold out of Cabot Corp (CBT) in Q1 2023, closing a stake of 19,988 shares — an estimated $1.34M sold.

Ergoteles first reported a position in CBT in Q4 2021 and held it in 3 quarters. The position peaked at $1.34M in Q4 2022. 304 funds tracked by Wall St. Rank hold CBT as of Q1 2023.

Ergoteles reported no remaining Cabot Corp position as of Q1 2023 after selling out during the quarter.
Ergoteles sold 19,988 Cabot Corp shares in Q1 2023, an estimated $1.34M.
Ergoteles first reported a position in Cabot Corp in Q4 2021 and held it in 3 quarters.
Ergoteles's Cabot Corp position peaked at $1.34M in Q4 2022.
304 funds tracked by Wall St. Rank held Cabot Corp as of Q1 2023.

Based on Ergoteles's 13F filing for Q1 2023, filed 10 May 2023.